To suspend temporarily the rate of duty on Vinyl acetate-Alkeneoic acid Copolymer.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2011 · first_quarter · Health Issues
PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 452 Medicare Decisions Accountability Act - repeal of Independent Payment Advisory Board (IPAB) S 668 Health Care Bureaucrats Elimination Act - repeal of Independent Payment Advisory Board (IPAB) S 296 Preserving Access to Life-Saving Medications Act - provisions related to drug access, drug pricing, generics and the FDA S 223 FAA Air Transportation Modernization and Safety Improvement Act - amendments related to Patient Protection and Affordable Care Act S 319 Pharmaceutical Market Access and Drug Safety Act of 2011 - drug safety and importation Access to Appropriate Immunizations for Veterans Act (currently unassigned) - reintroduction of HR 5516 in 112th Congress Federal Food, Drug, and Cosmetic Act (currently unassigned) - section related to FDA and regulation of nicotine replacement therapies Prescription Drug User Fee Act PDUFA-V (currently unassigned) - issues related to reauthorization of the Prescription Drug User Fee Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,490,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE